Tag: Cytokine
-
The molecular mayhem of immunogens, haptens, carriers and adjuvants
First up, the immunogen: the molecular maestro of the immune system, orchestrating a symphony of B-cells and T-cells like a conductor with a grudge. These substances don’t just knock politely on the immune system’s door—they kick it down with the force of a battering ram. Immunogens are a subset of antigens (because “antibody-generating” wasn’t obvious enough)…
-
The transforming growth factor beta receptors
a family of serine/threonine kinase receptors involved in TGF beta signaling pathway
-
PPARGC1A is also known as human accelerated region 20 (HAR20) and may have played a key role in differentiating humans from apes
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) is a protein that in humans is encoded by the PPARGC1A gene. PPARGC1A is also known as human accelerated region 20 (HAR20). It may, therefore, have played a key role in differentiating humans from apes. PGC-1α is the master regulator of mitochondrial biogenesis. PGC-1α is also the primary regulator of liver gluconeogenesis, inducing increased gene expression for gluconeogenesis. Function PGC-1α is a super…
-
Anti-thymocyte globulin (ATG)
Anti-thymocyte globulin (ATG) is an infusion of horse or rabbit-derived antibodies against human T cells and their precursors (thymocytes), which is used in the prevention and treatment of acute rejection in organ transplantation and therapy of aplastic anemia due to bone marrow insufficiency. Uses Two antithymocyte globulin (ATG) agents licensed for clinical use in the United States are Thymoglobulin (rabbit ATG, rATG, Genzyme) and…
-
Anti-lymphocyte globulin (ALG)
Anti-lymphocyte globulin (ALG) is an infusion of animal- antibodies against human T cells which is used in the treatment of acute rejection in organ transplantation. Its use was first reported by Thomas Starzl in 1966.[1] Its use in transplant was supplanted by thymoglobulin between 1984 and 1999.[2] It has also been used in the treatment of aplastic anemia.[3][4][5] It is less commonly used than the similar anti-thymocyte globulin (ATG), and like ATG it is…
